Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 73 of 114

  1. PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN

    Tour Hekla

    Recurrent Erysipelas in lower limbs

    phase 3 small molecule active

    1 trial

  2. PI23/00797

    The George Institute

    Acute Heart Failure

    phase 3 small molecule active

    1 trial

  3. PICO-TRAT

    Lacuna Pharma Pty Ltd

    Second line treatment for colonoscopy preparation

    phase 3 small molecule active

    1 trial

  4. PIPAC_VEROne

    Verona Pharma Ireland Limited

    Gastric adenocarcinoma with peritoneal metastases

    phase 3 small molecule active

    1 trial

  5. PKU-003

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonurias

    phase 3 small molecule completed

    1 trial

  6. PL2200 Aspirin Capsules

    Protalix BioTherapeutics

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    2 trials

  7. PLACEBO SOTAGLIFLOZIN, SOTAGLIFLOZIN

    LEXICON PHARMACEUTICALS, INC.

    Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy

    phase 3 small molecule active

    1 trial

  8. PLACEBO for amyotrophic lateral sclerosis

    Istituto Gentili S.r.l.

    amyotrophic lateral sclerosis

    phase 3 small molecule active

    1 trial

  9. PLASMA for Coagulation in pediatric cardia…

    Disc Medicine

    Coagulation in pediatric cardiac surgery

    phase 3 small molecule active

    1 trial

  10. PLX-200

    Polaryx Therapeutics

    Juvenile Neuronal Ceroid Lipofuscinosis

    phase 3 small molecule active

    1 trial

  11. PM1183-C-008-21

    Lacuna Pharma Pty Ltd

    Small Cell Lung Cancer (SCLC)

    phase 3 small molecule active

    1 trial

  12. PPP001

    Lacuna Pharma Pty Ltd

    Palmoplantar Pustulosis

    phase 3 small molecule active

    1 trial

  13. PPRO24-001

    Instituto Grifols S.A.

    Severe Alpha-1 Antitrypsin Deficiency (AATD)

    phase 3 small molecule active

    1 trial

  14. PR-30-5017-C

    TESARO Bio Netherlands B.V.

    Homologous recombination deficiency advanced ovarian cancer

    phase 3 small molecule active

    1 trial

  15. PRAX-114

    Chongqing Precision Biotech Co., Ltd

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  16. PRAX-222

    Chongqing Precision Biotech Co., Ltd

    Voltage-gated sodium channel type II alpha subunit (SCN2A) developmental and epileptic encephalopathy (DEE)

    phase 3 small molecule active

    1 trial

  17. PRAX-562

    Chongqing Precision Biotech Co., Ltd

    SCN2A Encephalopathy

    phase 3 small molecule active

    1 trial

  18. PRAX-628-322

    Chongqing Precision Biotech Co., Ltd

    Focal Epilepsy

    phase 3 small molecule active

    1 trial

  19. PRAX-628-323

    Chongqing Precision Biotech Co., Ltd

    Focal onset seizures or primary generalized tonic-clonic seizures.

    phase 3 small molecule active

    1 trial

  20. PREDNISONE for Idiopathic IgA nephropathy (IgAN)

    Fondazione Telethon ETS

    Idiopathic IgA nephropathy (IgAN)

    phase 3 small molecule active

    1 trial

  21. PREVENT-MINS

    COLLEGIUM PHARMACEUTICAL, INC

    Myocardial Injury after Noncardiac Surgery

    phase 3 small molecule active

    1 trial

  22. PRIDOPIDINE, Pridopidine placebo

    Ferrer Internacional S.A.

    Amyotrophic Lateral Sclerosis

    phase 3 small molecule active

    1 trial

  23. PRIN - 20227EA9AN

    Talion

    Major Depressive Disorder (MDD)

    phase 3 small molecule active

    1 trial

  24. PRIN - 20227EA9AN

    Talion

    Major Depressive Disorder (MDD)

    phase 3 small molecule active

    1 trial

  25. PRINCE

    Istituto Gentili S.r.l.

    End Stage Kidney Disease on chronic dialysis therapy

    phase 3 small molecule active

    1 trial

  26. PRISM-1

    Arcus Biosciences

    Pancreatic cancer, Metastatic Pancreatic ductal adenocarcinoma (mPDAC), Pancreatic ductal adenocarcinoma (PDAC)

    phase 3 small molecule active

    1 trial

  27. PRM-151 (Zinpentraxin Alfa)

    Hoffmann-La Roche

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule terminated

    1 trial

  28. PRO 2000/5

    United Therapeutics Europe Ltd

    HIV Infections

    phase 3 small molecule completed

    1 trial

  29. PRO-EV71CA16-3001

    Sinovac Research and Development Co.,

    Hand, Foot, and Mouth Disease（HFMD)

    phase 3 mab active

    1 trial

  30. PRO-PVRV-sf-3003

    Sinovac Research and Development Co.,

    Rabies

    phase 3 mab active

    2 trials

  31. PRO-QINF-3004

    Sinovac Research and Development Co.,

    Seasonal Influenza

    phase 3 mab completed

    1 trial

  32. PRO-RCT-ACAROS-2018

    Lacuna Pharma Pty Ltd

    Allergic rhinoconjunctivitis due to exposure of house dust mites

    phase 3 small molecule active

    1 trial

  33. PRO-VZV-4002

    Sinovac Research and Development Co.,

    Varicella

    phase 3 mab active

    1 trial

  34. PRO-nCOV-3001

    Sinovac Research and Development Co.,

    Covid19

    phase 3 mab completed

    1 trial

  35. PRO-onCOV-3001

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab completed

    1 trial

  36. PRO-sIPV-3002

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  37. PRO-tnCOV-3003

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab active

    1 trial

  38. PRODIGE 118-PEHRICCA

    CERO THERAPEUTICS HOLDINGS, INC.

    Hihg risk of cholangiocarcinoma intra hépatic resectable

    phase 3 small molecule active

    1 trial

  39. PRODIGE 49 -OSCAR

    CERO THERAPEUTICS HOLDINGS, INC.

    colon cancer and rectal with liver metastasis

    phase 3 small molecule active

    1 trial

  40. PRODIGE 51 - GASTFOX

    CERO THERAPEUTICS HOLDINGS, INC.

    Locally advanced or metastatic oesogastric adenocarcinoma

    phase 3 small molecule active

    1 trial

  41. PRODIGE85-KANALRAD

    CERO THERAPEUTICS HOLDINGS, INC.

    locally advanced anal squamous cell carcinoma

    phase 3 small molecule active

    1 trial

  42. PROGRAF for lung transplantation

    Disc Medicine

    lung transplantation

    phase 3 small molecule active

    1 trial

  43. PROICM 2018-01 NEX

    The George Institute

    Metastatic colorectal cancer

    phase 3 small molecule active

    1 trial

  44. PROICM 2021-01 GRE

    The George Institute

    Rectum cancer

    phase 3 small molecule active

    1 trial

  45. PROPRANOLOL

    Pari Pharma GmbH

    Von Hippel-Lindau (VHL) disease

    phase 3 small molecule active

    1 trial

  46. PROTO-BRAIN

    Tour Hekla

    Resistant Depression in the Elderly Subject

    phase 3 small molecule active

    1 trial

  47. PROVARIX

    Sinovac Research and Development Co.,

    Varicella (Chickenpox)

    phase 3 mab active

    1 trial

  48. PROVIGIL 200 mg

    Teva Pharma GmbH

    Chronic Shift Work Sleep Disorder

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.